A detailed history of Column Group LLC transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Column Group LLC holds 2,680,621 shares of RAPT stock, worth $2.81 Million. This represents 7.75% of its overall portfolio holdings.

Number of Shares
2,680,621
Previous 2,680,621 -0.0%
Holding current value
$2.81 Million
Previous $8.18 Million 34.09%
% of portfolio
7.75%
Previous 11.48%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$16.28 - $24.6 $2,653 - $4,009
163 Added 0.01%
2,680,621 $53.1 Million
Q2 2022

Aug 12, 2022

BUY
$10.26 - $23.59 $13.1 Million - $30.2 Million
1,278,450 Added 91.19%
2,680,458 $48.9 Million
Q3 2021

Nov 12, 2021

SELL
$29.86 - $39.47 $74.2 Million - $98 Million
-2,483,671 Reduced 63.92%
1,402,008 $43.5 Million
Q4 2020

Feb 16, 2021

BUY
$15.89 - $40.87 $61.7 Million - $159 Million
3,885,679 New
3,885,679 $76.7 Million

Others Institutions Holding RAPT

About RAPT Therapeutics, Inc.


  • Ticker RAPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,656,600
  • Market Cap $31.1M
  • Description
  • RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...
More about RAPT
Track This Portfolio

Track Column Group LLC Portfolio

Follow Column Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Column Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Column Group LLC with notifications on news.